Benefits
Long-term cognitive performance in middle-aged adults (PMC7468716)
PMC7468716 randomized double-blind placebo-controlled parallel study in 101 healthy middle-aged overweight adults. 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo for 24 weeks. RESULTS: SIGNIFICANT IMPROVEMENT in psychomotor speed (grooved pegboard test), focus (number cross-out), cognitive flexibility (Stroop test). Brain-derived neurotrophic factor (BDNF) maintenance documented. Foundational long-term RCT. Industry-funded (BioActor BV) but methodologically rigorous double-blind design.
Brain vascular function + cognition crossover trial (160 mg/day)
Recent crossover study (Clinical Nutrition publication) in 30 healthy overweight/obese older adults aged 59-71 years (BMI 26-31.4). 160 mg AME daily vs placebo. RESULTS: 20% IMPROVEMENT in cognitive performance, 10.8% reduction in regional cerebral blood flow. AME contained 25% anthocyanins (17% cyanidin-3-O-galactoside + 8% other cyanidin glycosides). Confirms vascular function + cognitive synergy. Smaller sample but strong methodology.
Acute short-term cognitive effects (7 days)
Two RCTs documented Brainberry® cognitive effects after 7-day acute consumption AND long-term 6-12 week consumption. Acute: focus and psychomotor control improvements. Sustained: cognitive flexibility, attention/concentration, reaction time, visual-motor coordination, BDNF maintenance. US patent issued specifically for cognitive performance support claims. Published in peer-reviewed literature (Solabia studies).
BDNF (brain-derived neurotrophic factor) maintenance
Brainberry® supports OPTIMAL BDNF levels — essential neurotrophin for synaptic plasticity, learning, memory, neuronal survival. BDNF declines with age; maintenance is mechanism for cognitive aging prevention. Distinguishes from acute symptomatic interventions. Mechanism via cyanidin-3-O-galactoside reaching CNS and modulating neurotrophic gene expression.
Cerebral perfusion enhancement (mechanism)
Cyanidin-3-O-galactoside crosses BBB and SYSTEMICALLY ENHANCES BRAIN PERFUSION + INCREASES OXYGEN UPTAKE per manufacturer characterization. Mechanism for combined cognitive + cerebrovascular benefits. Vascular endothelial function effects via anthocyanin polyphenol mechanisms (NO-mediated). Aronia berries also recognized for vascular protection in older literature.
Antioxidant + anti-inflammatory CNS effects
Anthocyanins suppress neuroinflammation and oxidative stress in CNS. Modulate pro-inflammatory signaling pathways, scavenge reactive oxygen species, enhance antioxidant defenses. Mechanism contributing to long-term neuroprotection. Aronia melanocarpa is among RICHEST natural sources of cyanidin glycosides — concentrated form via Nero Eggert variety + standardized extraction.
Mechanism of action
Cyanidin-3-O-galactoside BBB penetration (UNIQUE among anthocyanins)
Distinguishing feature: cyanidin-3-O-galactoside (Cy3Gal) is the most BBB-permeable cyanidin glycoside — crosses blood-brain barrier directly to exert CNS effects. Mechanism: galactoside sugar provides distinct membrane transport vs more common glucosides. Aronia melanocarpa naturally contains higher Cy3Gal proportion than other berries. Brainberry® standardization enriches this molecule for cognitive applications.
BDNF gene expression maintenance
Anthocyanin metabolites in CNS modulate neurotrophic factor gene expression — particularly BDNF and TrkB pathways. Mechanism for synaptic plasticity preservation, neurogenesis support, and cognitive maintenance with aging. Distinct from acute receptor modulation.
Vascular endothelial function and NO production
Anthocyanins improve endothelial function via increased nitric oxide (NO) production. Cerebrovascular effects translate to improved cerebral perfusion and oxygen delivery. Mechanism for combined cognitive + cardiovascular benefits.
Antioxidant via direct ROS scavenging
Direct scavenging of reactive oxygen species (hydroxyl, peroxyl, superoxide radicals). Particularly effective in CNS where oxidative stress contributes to age-related cognitive decline. Catechol and phenolic structure of anthocyanins provides electron-donating antioxidant activity.
Anti-inflammatory pathway modulation
Suppresses NF-κB, COX-2, iNOS, pro-inflammatory cytokines. Mechanism for chronic inflammation reduction in CNS — relevant to cognitive aging where neuroinflammation contributes to neuronal dysfunction.
Procyanidin synergy
Aronia berries also rich in PROCYANIDINS (oligomeric flavonoid polymers) that work synergistically with anthocyanins. Combined polyphenol matrix in Brainberry® provides multi-target effects beyond single-compound activity.
Clinical trials
Randomized double-blind placebo-controlled parallel study (PMC7468716, Nutrients 2020).
101 healthy middle-aged overweight adults. Three arms: 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo (maltodextrin). 24-week supplementation period. Cognitive tests: Stroop, grooved pegboard, number cross-out. Vascular function and BDNF measured.
SIGNIFICANT IMPROVEMENTS in psychomotor speed (grooved pegboard), focus (number cross-out), cognitive flexibility (Stroop). Long-term consumption pattern. BDNF maintenance documented. Foundational long-term RCT supporting Brainberry® cognitive claims and US patent. Industry-sponsored (BioActor BV) — important context for evidence interpretation.
Randomized double-blind placebo-controlled crossover study (Maastricht University Medical Center, Clinical Nutrition publication). NCT05268133 COMPLETED.
30 healthy overweight or obese older adults aged 59-71 years (BMI 26-31.4). 160 mg AME daily (containing 25% anthocyanins: 17% cyanidin-3-O-galactoside + 8% other cyanidin glycosides) vs placebo. Brain insulin-sensitivity and vascular function focus.
20% IMPROVEMENT in cognitive performance. 10.8% REDUCTION in regional cerebral blood flow. Brain vascular function improvements documented. Mechanism: cyanidin-3-O-galactoside BBB penetration enabling direct CNS effects. Smaller sample (n=30) but strong crossover methodology in higher-risk older population.
Randomized double-blind clinical trial in younger subjects (Solabia/BioActor reported study).
Younger subjects, 7-day acute and 12-week long-term consumption protocols.
ACUTE CONSUMPTION: focus and psycho-motor control improvements. SUSTAINED CONSUMPTION: cognitive flexibility, attention/concentration, reaction time, visual-motor coordination improvements. CONFIRMS effects across age groups (younger + older adults). Foundational evidence for US patent issuance.
About this ingredient
Brainberry® is a CLINICALLY VALIDATED standardized extract of ARONIA MELANOCARPA (BLACK CHOKEBERRY), specifically the NERO EGGERT variety from the Baltic region. Developed by BioActor BV (Netherlands), now under SOLABIA NUTRITION. Standardized to 15-18% total anthocyanins, with EMPHASIS on CYANIDIN-3-O-GALACTOSIDE (Cy3Gal) — the hero compound that DISTINGUISHES Brainberry® from other anthocyanin extracts. Cy3Gal crosses BBB more efficiently than common cyanidin-3-glucoside found in most berries. Aronia melanocarpa is naturally one of the RICHEST natural sources of cyanidin glycosides — Brainberry® concentrates and standardizes this for cognitive applications. Additional anthocyanins: cyanidin-3-arabinoside, cyanidin-3-xyloside, cyanidin-3-glucoside. Procyanidins (oligomeric flavonoids) also present. CLINICAL EVIDENCE BASE: TWO published RCTs supporting cognitive claims. PIVOTAL: PMC7468716 24-week parallel study (n=101) middle-aged overweight adults showing psychomotor speed, focus, cognitive flexibility improvements at 90-150 mg/day. CROSSOVER: Maastricht/Clinical Nutrition study (n=30) older adults 59-71 years showing 20% cognitive improvement + 10.8% regional cerebral blood flow change at 160 mg/day. ADDITIONAL: shorter-duration acute consumption studies in younger subjects showing similar pattern. US PATENT issued for cognitive performance support claims — significant regulatory/IP recognition. Solabia describes Brainberry® mechanism as: 'systemically enhances brain perfusion and increases oxygen uptake' via Cy3Gal BBB penetration.
MECHANISMS: Cy3Gal BBB penetration (unique among anthocyanins), BDNF gene expression maintenance, vascular endothelial function via NO production, ROS scavenging antioxidant activity, NF-κB/COX-2 anti-inflammatory pathway modulation, procyanidin polyphenol synergy. EVIDENCE: 2/5 reflects: (1) PMC7468716 PIVOTAL 24-week RCT (n=101), (2) crossover study (n=30) confirming cognitive + brain vascular benefits, (3) US patent issuance for cognitive performance support, (4) industry-sponsored evidence (BioActor/Solabia) — important context for interpretation, (5) WELL-CHARACTERIZED Cy3Gal BBB penetration mechanism, (6) double-blind RCT methodology, (7) BDNF maintenance evidence supporting long-term cognitive aging applications. SAFETY: Excellent — derived from food berry with extensive Russian/Eastern European traditional consumption. Best positioned as: (a) COGNITIVE AGING PREVENTION adjunct in middle-aged through older adults, (b) FOCUS/PSYCHOMOTOR PERFORMANCE adjunct for sustained mental tasks, (c) BRAIN VASCULAR FUNCTION adjunct in overweight/older adults at cognitive risk, (d) BDNF MAINTENANCE adjunct for long-term cognitive resilience, (e) DAILY USE acceptable based on safety profile, (f) industry-sponsored evidence — independent replication welcomed but methodologically rigorous, (g) higher-evidence than typical 'aronia supplement' due to Cy3Gal standardization and dedicated RCTs. Honest framing: Brainberry® has more rigorous evidence than typical branded berry extracts — pivotal 24-week RCT in middle-aged adults plus crossover trial in older adults plus US patent represents a real evidence base. Industry sponsorship (Solabia) warrants caveat but methodology is sound. The Cy3Gal BBB penetration mechanism is biochemically distinctive among anthocyanin extracts. Reasonable cognitive aging adjunct based on evidence.